United States
Joined April 2025
- Tweets164
- Following49
- Followers149
- Likes120
Pinned Tweet
🎉 Big news! The new ASPIRE Special Interest Group at #SITC26 holds its first in-person meet-up.
📅 Nov 7, 7:10–7:40 PM at the SITC booth in Phoenix. 🌵
Come connect, share ideas & help build the SIG.
Appetizers & drinks on us! 🍽️
#irAE #immunotherapy
@KMittalmd @sitcancer
ASPIRE Community of Practice retweeted
Congratulations to our team @ASPIRE_CoP for starting this special interest group @sitcancer
See our latest newsletter to learn about the upcoming get together at the annual @sitcancer meeting
Connect with SITC members who share your scientific interests! Explore SITC’s three active Special Interest Groups (SIGs): ASPIRE, Peri-IO Safety and Microbiome. Discover opportunities to network, collaborate and advance cancer immunotherapy. Learn more: sitcancer.org/get-involved/s…
📚 Reading recs from ASPIRE:
• First-line FMT for ICI colitis: ~77% improved, symptoms resolved in a median of 1.5 days
• Recurrent ICI arthritis: the same infl T cells in first and later flares
Links 👉 pubmed.ncbi.nlm.nih.gov/4273…
pubmed.ncbi.nlm.nih.gov/4253…
#irAE #immunotherapy
ASPIRE Community of Practice retweeted
Drs Andrew Trinh and Sophia Ling are fantastic gastroenterology colleagues @PeterMacCC
Thanks so much for helping @NzsOncology put together this free irAE webinar series 🤩 great resource!
@MOGA_ORG @ONCOassist @OncoAlert @ASPIRE_CoP @IndianYoungOnco @oncodaily
The latest of our #NZSOimmunotoxwebinar series is now available online as a FREE resource for any to use and reference! Share widely amongst colleagues 👉nzsoncology.org.nz/webinarse…
ASPIRE, a community of practice of @ASCO is proud to present a virtual webinar on Elevating Patient Voices in the Management of irAEs.
Join us today at 4 pm EST for our Quarterly Webinar series with hosts @KMittalmd and @afreenshariffmd
🔗 in flyer ⬇️
📢 ASPIRE Quarterly Webinar
Elevating Patient Voices & Management of #irAEs
📆 Tues 9/22 · 4:00–5:30 PM ET
🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos
🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd
💻 Zoom🔗: us.list-manage.com/1B14TXB1R…
#Oncology
📢 ASPIRE Quarterly Webinar
Elevating Patient Voices & Management of #irAEs
📆 Tues 9/22 · 4:00–5:30 PM ET
🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos
🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd
💻 Zoom🔗: us.list-manage.com/1B14TXB1R…
#Oncology
Residents & fellows: how are you learning about immune-related adverse events?
⏱️ 5 minutes
🔒 Anonymous
✅ No right or wrong answers
Help ASPIRE's Community Education Committee build better irAE education 👇
🚨 Aug 18: ASPIRE case discussion on immunotherapy toxicity
🧠 Neuro — John Probasco, MD (Hopkins)
🩹 Skin — Silvina Pugliese, MD (NYU)
Moderators: Aliyah Pabani, MD & Stephane Champiat, MD, PhD
5:30–6:30 PM CST | CME 51508
tinyurl.com/yck5afku
#irAE #Oncology
@KMittalmd
ASPIRE Community of Practice retweeted
@ASPIRE_CoP members please take note!
🚨irAE aficianados! Open comment for Renal, Musculoskeletal, and Cardiac adverse events sections of the @ASCO irAE guidelines are now available through August 28th at:
asco1.qualtrics.com/jfe/form…
As everything with irAE, it's a team sport. We want to hear your comments!
Please share with your trainees- to help us design evidence based education pertaining to irAEs.
cc: @DrKarineTawagi @ASridharMD @NazliDizman @FunchainMD @PGrivasMDPhD
⏰ Starting in 15 minutes!
Join ASPIRE's webinar "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" — 4 PM EST with our expert panel. Hop on 👉 shorturl.at/B2zt2
#irAE #immunotherapy #oncology
Glad to see some of our Executive Committee members on this- @ASPIRE_CoP remains committed to fostering a community of #irAE clinicians, educators and researchers!
@FunchainMD @thenasheffect
Today's @sitcancer program on immunotherapy toxicity management felt less like a webinar and more like a conversation among colleagues.
#irAEs remain one of the areas where clinical experience is often ahead of the evidence, making discussions like these particularly valuable.
A pleasure to share the session with such a great faculty panel and many friends across the field.
@kreynoldsMD @thenasheffect @EladSharonMD @FunchainMD @LKottschadeCNP Ryan Sullivan, Matthew Lei, Aleksandra Kukla.
Thanks to @sitcancer for the invitation and the discussion!
@Surgeon_General
@CampusBioMedico
@PoliclinCampus
Here’s a 🔗 to the newsletter
mailchi.mp/1e6c4c8aed14/f9hi…
Don’t forget to log in for our June 17 ASCO irAE webinar!
ASPIRE Community of Practice retweeted
If you are a resident or fellow (in any specialty) please consider taking this survey to help ASPIRE develop #irAE and IOTOX education resources for medical trainees @FunchainMD @ASridharMD @DrKarineTawagi @mhadfield30 @OncBrothers @OncoAlert
If you are a resident or fellow (in any specialty) please consider taking this survey to help ASPIRE develop #irAE and IOTOX education resources for medical trainees @FunchainMD @ASridharMD @DrKarineTawagi @mhadfield30 @OncBrothers @OncoAlert
📢 Residents & Fellows: Help shape the future of immunotherapy education! Participate in our 5-min anonymous survey on #irAE experiences.🩺
Program directors and faculty—please share with your trainees!
Complete the survey:🔗 shorturl.at/GMNMY
#ASPIRECOP #OncMedEd
Couldn't catch every #irAE session at #ASCO26?
We've got you! 🧡
Join @ASPIRE_CoP, @FunchainMD, @mhadfield30, @LZubiriOteiza & Dr. Pabani for ASPIRE's post-ASCO webinar
📅 June 17, 4 PM EST
Free to join 👉shorturl.at/B2zt2
#immunotherapy
ASPIRE Community of Practice retweeted
🚨irAE aficianados! Help shape @ASCO guidelines in part 1 of open comment on the next iteration of ASCO's irAE guidelines. Open for comment until Wed 6/10 ✍️
Part 1: 🫁👁️👄
Link to comment here 👇
asco1.qualtrics.com/jfe/form…
